1. April 2025 – MedComms Experts (MCE), a global provider of rare-disease-focused medical communications services, has announced a strategic investment by The Brydon Group (Brydon). MCE bridges the gap between its global base of biopharma clients and healthcare professionals via high-science content and effective communication strategies that facilitate understanding of rare disease therapies. As part of the investment, Brydon will make significant investments into furthering MCE's services, and into new technologies that will allow MCE to stay at the forefront of scientific creativity.

Walder Wyss acted as counsel to MCE in this transaction. The team was led by Luc Defferrard (Partner, Corporate/M&A) and included Michael Kündig (Managing Associate, Corporate/M&A) and Janine Corti (Counsel, Tax).